Work

A Phase II Trial of the Combination of Obinutuzumab, Venetoclax, and Ibrutinib in Patients with Previously Untreated Follicular Lymphoma

Year: 2022

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood-2022-164905

Authors: Tamer Othman, Aaron S Rosenberg, John Timmerman, Benjamin Heyman, Haifaa Abdulhaq, Joseph M Tuscano

Institutions: UC Davis Comprehensive Cancer Center, University of California, Davis, UC Davis Health, Ronald Reagan UCLA Medical Center, University of California San Diego, Moores Cancer Center, University of California, San Francisco

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310099669

FWCI: 0.169

Cites:

Cited by: 1

Related to: 10